0001596771-15-000079.txt : 20151201 0001596771-15-000079.hdr.sgml : 20151201 20151201165523 ACCESSION NUMBER: 0001596771-15-000079 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151201 FILED AS OF DATE: 20151201 DATE AS OF CHANGE: 20151201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Diplomat Pharmacy, Inc. CENTRAL INDEX KEY: 0001610092 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 382063100 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4100 S. SAGINAW ST. CITY: FLINT STATE: MI ZIP: 48507 BUSINESS PHONE: 888-720-4450 MAIL ADDRESS: STREET 1: 4100 S. SAGINAW ST. CITY: FLINT STATE: MI ZIP: 48507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaddis Atheer A CENTRAL INDEX KEY: 0001619008 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36677 FILM NUMBER: 151262876 MAIL ADDRESS: STREET 1: 4100 S. SAGINAW STREET CITY: FLINT STATE: MI ZIP: 48507 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-12-01 0 0001610092 Diplomat Pharmacy, Inc. DPLO 0001619008 Kaddis Atheer A 4100 S. SAGINAW STREET FLINT MI 48507 0 1 0 0 SVP of Sales & Business Dev Common Stock 2015-12-01 4 M 0 12325 3.07 A 12325 D Common Stock 2015-12-01 4 S 0 12325 34.7493 D 0 D Employee Stock Option to Acquire Common Stock 3.07 2015-12-01 4 M 0 12325 0 D 2019-04-01 Common Stock 12325 394400 D The sale was effected pursuant to a 10b5-1 trading plan initially adopted by the reporting person on August 6, 2015. The plan provides for monthly sales of 12,325 shares of common stock at the market price. Shares that are not sold in a particular month will be available for sale in subsequent months under the plan. A maximum of 98,600 shares remain available for sale under the plan, which is set to expire on August 31, 2016. The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging fro $34.31 to $35.03 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. The options were granted on April 1, 2009. The options began to vest in annual increments of 25% of the option grant on the one-year anniversary of the grant date, to be fully vested after four years. 100% of the options originally granted are currently vested and exercisable. Jeffrey H. Kuras, Attorney-in-fact 2015-12-01